The deindustrialization of America: Plant closings, community abandonment, and the dismantling of basic industry B Bluestone, B Harrison (No Title), 1982 | 5817 | 1982 |
CD28/B7 system of T cell costimulation DJ Lenschow, TL Walunas, JA Bluestone Annual review of immunology 14 (1), 233-258, 1996 | 3711 | 1996 |
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 EA Tivol, F Borriello, AN Schweitzer, WP Lynch, JA Bluestone, AH Sharpe Immunity 3 (5), 541-547, 1995 | 3631 | 1995 |
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells W Liu, AL Putnam, Z Xu-Yu, GL Szot, MR Lee, S Zhu, PA Gottlieb, ... The Journal of experimental medicine 203 (7), 1701-1711, 2006 | 3482 | 2006 |
CTLA-4 can function as a negative regulator of T cell activation TL Walunas, DJ Lenschow, CY Bakker, PS Linsley, GJ Freeman, ... Immunity 1 (5), 405-413, 1994 | 2758 | 1994 |
B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T cells that control autoimmune diabetes B Salomon, DJ Lenschow, L Rhee, N Ashourian, B Singh, A Sharpe, ... Immunity 12 (4), 431-440, 2000 | 2626 | 2000 |
International trial of the Edmonton protocol for islet transplantation AMJ Shapiro, C Ricordi, BJ Hering, H Auchincloss, R Lindblad, ... New England Journal of Medicine 355 (13), 1318-1330, 2006 | 2473 | 2006 |
Innate immunity and intestinal microbiota in the development of Type 1 diabetes L Wen, RE Ley, PY Volchkov, PB Stranges, L Avanesyan, AC Stonebraker, ... Nature 455 (7216), 1109-1113, 2008 | 2214 | 2008 |
Identification of a monoclonal antibody specific for a murine T3 polypeptide. O Leo, M Foo, DH Sachs, LE Samelson, JA Bluestone Proceedings of the National Academy of Sciences 84 (5), 1374-1378, 1987 | 2102 | 1987 |
Natural versus adaptive regulatory T cells JA Bluestone, AK Abbas Nature Reviews Immunology 3 (3), 253-257, 2003 | 2009 | 2003 |
The B7 and CD28 receptor families CH June, JA Bluestone, LM Nadler, CB Thompson Immunology today 15 (7), 321-331, 1994 | 1792 | 1994 |
High association of an HL-A antigen, W27, with ankylosing spondylitis L Schlosstein, PI Terasaki, R Bluestone, CM Pearson New England Journal of Medicine 288 (14), 704-706, 1973 | 1743 | 1973 |
The great U-turn: Corporate restructuring and the polarizing of America B Harrison, B Bluestone (No Title), 1988 | 1717 | 1988 |
Genetics, pathogenesis and clinical interventions in type 1 diabetes JA Bluestone, K Herold, G Eisenbarth Nature 464 (7293), 1293-1300, 2010 | 1579 | 2010 |
Relapsing polychondritis: prospective study of 23 patients and a review of the literature LP McADAM, MA O'HANLAN, R Bluestone, CM Pearson Medicine 55 (3), 193-215, 1976 | 1514 | 1976 |
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg DJ Lenschow, Y Zeng, JR Thistlethwaite, A Montag, W Brady, MG Gibson, ... Science 257 (5071), 789-792, 1992 | 1504 | 1992 |
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo X Zhou, SL Bailey-Bucktrout, LT Jeker, C Penaranda, ... Nature immunology 10 (9), 1000-1007, 2009 | 1467 | 2009 |
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus KC Herold, W Hagopian, JA Auger, E Poumian-Ruiz, L Taylor, ... New England Journal of Medicine 346 (22), 1692-1698, 2002 | 1465 | 2002 |
In vitro–expanded antigen-specific regulatory T cells suppress autoimmune diabetes Q Tang, KJ Henriksen, M Bi, EB Finger, G Szot, J Ye, EL Masteller, ... The Journal of experimental medicine 199 (11), 1455-1465, 2004 | 1463 | 2004 |
Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation B Salomon, JA Bluestone Annual review of immunology 19 (1), 225-252, 2001 | 1409 | 2001 |